Moderna's CMV trial offers further upside - UBS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. NVDA
2. PCG
3. AMZN
4. AVGO
5. AAPL
6. ALNY
7. CNS
8. STLA
9. EC
10. SRE

Go back to Moderna's CMV trial offers further upside - UBS
Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 140.34 +2.35 (1.70%)
Previous Close $137.99    52 Week High $0.52 
Open $134.10    52 Week Low $0.08 
Day High $144.20    P/E N/A 
Day Low $133.86    EPS $-3.80 
Volume 18,573,058